Login or sign up
For business

Arcus biosciences

3.9ยท 12 reviews
Average ratingAverage
3.9/ 5

Based on 12 reviews

525%
442%
333%
20%
10%
Ask AI

Ask Trustburn about Arcus biosciences

Based on 12 reviews on Trustburn

AI-generated from reviews on this page. Verify anything important with the company directly.

Carla Mazza
Reviews 1

I recently had the chance to work with Arcus Biosciences, and I have to say, they exceeded my expectations. The team is highly knowledgeable and dedicated to providing excellent services. Their website is user-friendly and offers all the necessary information. I would highly recommend them for any bioscience needs.

Sofia Alden
Reviews 1

The experience with Arcus Biosciences has been truly great. The company provides excellent services and has a highly skilled team. I am impressed with their dedication and commitment to innovation. The website is user-friendly and provides all the necessary information about their products and services. I highly recommend Arcus Biosciences to anyone in need of bioscience solutions.

Holly Hamby
Reviews 1

I recently had the opportunity to work with a bioscience company and had a really positive experience. The company provided outstanding services and had a highly skilled team. I was impressed with their dedication to innovation and their commitment to providing high-quality solutions. The website was user-friendly and provided all the necessary information. I would highly recommend them to anyone in need of bioscience solutions.

Gregoire Fourny
Reviews 1

I had a truly amazing experience with Arcus Biosciences. The company is dedicated to providing excellent services and has a highly skilled team. Their website is user-friendly and provides all the necessary information. I highly recommend them to anyone looking for bioscience solutions.

Joseph Bisaccia
Reviews 1

I recently worked with Arcus Biosciences and had a positive experience. The team is highly skilled and dedicated to providing excellent services. Their website is user-friendly and informative. I would recommend them to anyone looking for bioscience solutions.

Vyacheslav Ananyev
Reviews 1

Arcus Biosciences provided me with exceptional services. The team is highly skilled and dedicated to their work. I was impressed with their website, which is user-friendly and provides all the necessary information. I would recommend them to anyone in need of bioscience solutions.

Anila Andrade
Reviews 1

๐Ÿ‘Œ Arcus Biosciences is an excellent company providing top-notch services. Their team is highly skilled and dedicated to innovation. I had a great experience with their website, which is user-friendly and informative. I would highly recommend them to anyone in need of bioscience solutions.

News

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying a widget on your website โ€” a simple way to convert your visitors into customers.

Get the widget for your site →

About Arcus biosciences

Arcus is a biopharmaceutical company aiming to bring together scientists, physicians & advisors to focus on developing best-in-class cancer therapies.

Arcus Biosciences: Revolutionizing Cancer Therapies

Arcus Biosciences is a biopharmaceutical company that has been making waves in the field of cancer research. The company was founded in 2015 with the aim of bringing together scientists, physicians, and advisors to focus on developing best-in-class cancer therapies. Since then, Arcus has been at the forefront of innovation in cancer treatment.

The company's mission is to develop breakthrough therapies that can transform the lives of patients with cancer. To achieve this goal, Arcus has assembled a team of world-class scientists and researchers who are dedicated to discovering new ways to treat this devastating disease.

One of the key areas where Arcus is making significant progress is in immunotherapy. Immunotherapy is an approach that harnesses the power of a patient's own immune system to fight cancer. This approach has shown great promise in recent years, and Arcus is at the forefront of developing new immunotherapies that can help more patients.

Arcus' lead product candidate is AB928, which targets two different receptors on immune cells called adenosine A2a and A2b receptors. By blocking these receptors, AB928 can enhance anti-tumor immunity by increasing T cell activation and reducing tumor-associated inflammation.

In addition to AB928, Arcus has several other promising product candidates in its pipeline. These include:

- AB680: An oral small molecule inhibitor targeting CD73 for potential use as a monotherapy or combination therapy with other agents.

- AB154: A monoclonal antibody targeting TIGIT (T-cell immunoreceptor with Ig and ITIM domains) for potential use as a monotherapy or combination therapy with other agents.

- AB308: A monoclonal antibody targeting TIM-3 (T-cell immunoglobulin mucin receptor 3) for potential use as a monotherapy or combination therapy with other agents.

All these products have shown promising results in preclinical studies and early-stage clinical trials. If successful, they could represent major breakthroughs in cancer treatment.

But what sets Arcus apart from other biopharmaceutical companies? One factor is its unique approach to drug development. Rather than focusing solely on one target or pathway, Arcus takes a more holistic approach by looking at multiple targets simultaneously. This allows them to develop drugs that are more effective than those developed using traditional approaches.

Another factor that sets Arcus apart is its commitment to collaboration. The company works closely with academic institutions, research organizations, and industry partners around the world to advance its research programs quickly and efficiently.

Finally, it's worth noting that Arcus' leadership team includes some of the most experienced executives in biotech today. CEO Terry Rosen co-founded Flexion Therapeutics (NASDAQ: FLXN), which went public in 2014; CMO Eric Hoefer previously served as VP Clinical Development at Genentech; CFO Jennifer Jarrett previously served as CFO at Medivation before it was acquired by Pfizer; COO Juan Jaen previously served as SVP Research & Development at MedImmune/AstraZeneca; CSO Bill Grossman previously served as VP Oncology Research & Early Development at Genentech/Roche; CBO Chris Haqq previously served as SVP Corporate Development & Strategy at Agios Pharmaceuticals (NASDAQ: AGIO).

In conclusion

Arcus Biosciences represents an exciting opportunity for investors looking for exposure to cutting-edge developments within oncology drug development space while also providing hope for millions suffering from various forms cancers worldwide through their innovative approaches towards drug discovery process coupled up their commitment towards collaboration across various stakeholders within healthcare ecosystem including academia institutions ,research organizations ,industry partners etc . With an experienced leadership team driving innovation forward alongside strong partnerships across industry verticals globally - there's no doubt about why this company should be on your radar if you're interested investing into future healthcare innovations!

Address
3928 point eden way
Categories
Biotechnology